Verisante Technology Inc. V.VRS

Aura roll-out

[herbacious]

Verisante hopes to have Aura on the market in Europe, Canada and Australia later this year and in the U.S in 2013.
Their plan is to initially target early adopters i.e-dermatologists, physicians that quickly indentify with the benifits of the technology.
This not only represents the low hanging frit, it will also hopefully drive acceptance and adoption of the technology by general practitioners, which represent a significantly larger target market.

gaining traction in Europe, Canada,and Australia could only benifit roll-out in the U>S>
The enormous size of the combined markets which Verisante is targeting means only low-single digit penetration could be highly significant for the company's size.

using rough estimates the combined number of dermatologists i Canada, europe, and Australia at about 21k (about 1k in Canada and Australia) roughly twice the number in the U>S>.

There are approximately 350k primary care physcians in the U>S>, Canada and Australia both have about 30k each UK is estimated to have 560k.

COMMERCIAL PROTOTYPE CURRENTLY UNDER DEVELOPMENT AND EXPECTED TO BE COMPLETED LATER IN 2011,

CURRANT TIME LINES PUT LAUNCH IN EUROPE, CANADA AND AUSTRALIA IN 2012, U.S LAUNCH COULD COME IN LATE 2013

FOLLOW UP PRODUCTS FOR DETECTION OF CANCERS OF THE LUNG, COLON,AND CERVIX ARE ALSO IN  THE FUTURE MAKING.


do your own due diligence

herb